Literature DB >> 26670633

von Willebrand factor is dimerized by protein disulfide isomerase.

Svenja Lippok1, Katra Kolšek2, Achim Löf1, Dennis Eggert3, Willem Vanderlinden4, Jochen P Müller1, Gesa König5, Tobias Obser5, Karoline Röhrs5, Sonja Schneppenheim6, Ulrich Budde6, Carsten Baldauf7, Camilo Aponte-Santamaría2, Frauke Gräter2, Reinhard Schneppenheim5, Joachim O Rädler1, Maria A Brehm5.   

Abstract

Multimeric von Willebrand factor (VWF) is essential for primary hemostasis. The biosynthesis of VWF high-molecular-weight multimers requires spatial separation of each step because of varying pH value requirements. VWF is dimerized in the endoplasmic reticulum by formation of disulfide bonds between the C-terminal cysteine knot (CK) domains of 2 monomers. Here, we investigated the basic question of which protein catalyzes the dimerization. We examined the putative interaction of VWF and the protein disulfide isomerase PDIA1, which has previously been used to visualize endoplasmic reticulum localization of VWF. Excitingly, we were able to visualize the PDI-VWF dimer complex by high-resolution stochastic optical reconstruction microscopy and atomic force microscopy. We proved and quantified direct binding of PDIA1 to VWF, using microscale thermophoresis and fluorescence correlation spectroscopy (dissociation constants KD = 236 ± 66 nM and KD = 282 ± 123 nM by microscale thermophoresis and fluorescence correlation spectroscopy, respectively). The similar KD (258 ± 104 nM) measured for PDI interaction with the isolated CK domain and the atomic force microscopy images strongly indicate that PDIA1 binds exclusively to the CK domain, suggesting a key role of PDIA1 in VWF dimerization. On the basis of protein-protein docking and molecular dynamics simulations, combined with fluorescence microscopy studies of VWF CK-domain mutants, we suggest the following mechanism of VWF dimerization: PDI initiates VWF dimerization by forming the first 2 disulfide bonds Cys2771-2773' and Cys2771'-2773. Subsequently, the third bond, Cys2811-2811', is formed, presumably to protect the first 2 bonds from reduction, thereby rendering dimerization irreversible. This study deepens our understanding of the mechanism of VWF dimerization and the pathophysiological consequences of its inhibition.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26670633     DOI: 10.1182/blood-2015-04-641902

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  The intersection of protein disulfide isomerase and cancer associated thrombosis.

Authors:  Jack D Stopa; Jeffrey I Zwicker
Journal:  Thromb Res       Date:  2018-04       Impact factor: 3.944

2.  Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.

Authors:  Alexander Tischer; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Matthew Auton
Journal:  J Thromb Haemost       Date:  2019-09-03       Impact factor: 5.824

3.  Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.

Authors:  Saravanan Subramaniam; Kerstin Jurk; Lukas Hobohm; Sven Jäckel; Mona Saffarzadeh; Kathrin Schwierczek; Philip Wenzel; Florian Langer; Christoph Reinhardt; Wolfram Ruf
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

4.  A proximity-based in silico approach to identify redox-labile disulfide bonds: The example of FVIII.

Authors:  Andrea Arsiccio; Clive Metcalfe; Roberto Pisano; Sanj Raut; Carmen Coxon
Journal:  PLoS One       Date:  2022-02-07       Impact factor: 3.240

5.  pH-Dependent Interactions in Dimers Govern the Mechanics and Structure of von Willebrand Factor.

Authors:  Jochen P Müller; Achim Löf; Salomé Mielke; Tobias Obser; Linda K Bruetzel; Willem Vanderlinden; Jan Lipfert; Reinhard Schneppenheim; Martin Benoit
Journal:  Biophys J       Date:  2016-07-26       Impact factor: 4.033

6.  Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.

Authors:  Alexander Tischer; Maria A Brehm; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Katelynn J Nelton; Rachel R Leger; Tobias Obser; Marina Martinez-Vargas; Steven T Whitten; Dong Chen; Rajiv K Pruthi; H Robert Bergen; Miguel A Cruz; Reinhard Schneppenheim; Matthew Auton
Journal:  J Mol Biol       Date:  2019-10-17       Impact factor: 5.469

7.  Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study.

Authors:  Taleen A MacArthur; Julie Goswami; Laurie Moon Tasson; Alexander Tischer; Kent R Bailey; Grant M Spears; Jing-Fei Dong; Matthew Auton; Rosemary Kozar; Myung S Park
Journal:  Trauma Surg Acute Care Open       Date:  2021-04-05

8.  Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging.

Authors:  Achim Löf; Gesa König; Sonja Schneppenheim; Reinhard Schneppenheim; Martin Benoit; Ulrich Budde; Jochen P Müller; Maria A Brehm
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

9.  Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA.

Authors:  Annika de Jong; Richard J Dirven; Johan Boender; Ferdows Atiq; Seyed Yahya Anvar; Frank W G Leebeek; Bart J M van Vlijmen; Jeroen Eikenboom
Journal:  Thromb Haemost       Date:  2020-08-15       Impact factor: 5.249

10.  A Homozygous Deep Intronic Variant Causes Von Willebrand Factor Deficiency and Lack of Endothelial-Specific Secretory Organelles, Weibel-Palade Bodies.

Authors:  Hamideh Yadegari; Muhammad Ahmer Jamil; Natascha Marquardt; Johannes Oldenburg
Journal:  Int J Mol Sci       Date:  2022-03-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.